1. Home
  2. NTHI vs CHMI Comparison

NTHI vs CHMI Comparison

Compare NTHI & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeOnc Technologies Holdings Inc.

NTHI

NeOnc Technologies Holdings Inc.

HOLD

Current Price

$3.44

Market Cap

114.6M

Sector

Health Care

ML Signal

HOLD

Logo Cherry Hill Mortgage Investment Corporation

CHMI

Cherry Hill Mortgage Investment Corporation

HOLD

Current Price

$2.24

Market Cap

95.5M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTHI
CHMI
Founded
2008
2012
Country
United States
United States
Employees
5
14
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
114.6M
95.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NTHI
CHMI
Price
$3.44
$2.24
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$15.00
$3.00
AVG Volume (30 Days)
65.4K
174.0K
Earning Date
05-19-2026
05-07-2026
Dividend Yield
N/A
15.09%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$61.13
P/E Ratio
N/A
$139.30
Revenue Growth
N/A
N/A
52 Week Low
$3.01
$2.17
52 Week High
$12.99
$3.04

Technical Indicators

Market Signals
Indicator
NTHI
CHMI
Relative Strength Index (RSI) 35.86 39.29
Support Level $3.01 $2.17
Resistance Level $4.59 $2.46
Average True Range (ATR) 0.38 0.05
MACD -0.03 -0.00
Stochastic Oscillator 25.55 13.10

Price Performance

Historical Comparison
NTHI
CHMI

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp is a fully integrated, internally managed residential real estate finance company focused on acquiring, investing in and managing residential mortgage assets in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

Share on Social Networks: